What is MaxCyte's financing cash flow?

MaxCyte (MXCT) reported financing cash flow of $5K in Q1 2026.

How has MaxCyte's financing cash flow changed year-over-year?

MaxCyte's financing cash flow decreased by 98.7% year-over-year, from $383K to $5K.

What is the long-term trend for MaxCyte's financing cash flow?

Over 4 years (2021 to 2025), MaxCyte's financing cash flow has grown at a -77.0% compound annual growth rate (CAGR), from $234.72M to $656K.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

MaxCyte MXCT Financing Cash Flow

Financing Cash Flow at other companies

Bio-Rad LaboratoriesBIO

-$44M+55.0%

Thermo Fisher ScientificTMO

$1.09B+1,172%

Ginkgo BioworksDNA

-$19K+90.8%

Immix Biopharma, Inc.IMMX

-$37.56K—

Rapid Micro BiosystemsRPID

$247K-34.8%

PDE

Pro-Dex, Inc.PDEX

-$5M-398%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's financing cash flow?: MaxCyte (MXCT) reported financing cash flow of $5K in Q1 2026.
How has MaxCyte's financing cash flow changed year-over-year?: MaxCyte's financing cash flow decreased by 98.7% year-over-year, from $383K to $5K.
What is the long-term trend for MaxCyte's financing cash flow?: Over 4 years (2021 to 2025), MaxCyte's financing cash flow has grown at a -77.0% compound annual growth rate (CAGR), from $234.72M to $656K.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.